Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS

NCT04987671 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

ALS

Interventions

DRUG: AMX0035

Sponsor

Amylyx Pharmaceuticals Inc.